The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms

2011 ◽  
Vol 52 (5) ◽  
pp. 754-763 ◽  
Author(s):  
Philip C. Amrein
2017 ◽  
Vol 37 (4) ◽  
pp. 336-338
Author(s):  
Hye-Young Lee ◽  
Chan-Jeoung Park ◽  
Enkyung You ◽  
Young-Uk Cho ◽  
Seongsoo Jang ◽  
...  

2013 ◽  
Vol 93 (4) ◽  
pp. 699-702 ◽  
Author(s):  
Ricardo García-Muñoz ◽  
Diana K. García ◽  
Verónica Roldán-Galiacho ◽  
Miriam Merchante-Andreu ◽  
Andrea Campeny-Najara ◽  
...  

2021 ◽  
Vol 29 (1) ◽  
pp. 130-133
Author(s):  
Marta Sofia Fernandes ◽  
Joana Martins ◽  
Maria Antónia Campos ◽  
Cacilda Magalhães ◽  
Yuliana O. Eremina

Chronic lymphocytic leukemia (CLL) and acute myeloid leukemia (AML) coexistence in the same patient has been rarely reported, more frequently due to treatment with chemotherapeutic agents. Blood parameter changes in cancer patients may be interpreted as disease progression or iatrogenic effects related to aggressive treatment, leading to delayed diagnosis. In our article, we call attention to the possibility of AML development in CLL patients and its diagnostic challenge.


Sign in / Sign up

Export Citation Format

Share Document